Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    PDT - Product Showcase

    • 00:00 - 23:59
    • 9/08/2021
    • Location: Product Theater
    • Type: Product Showcase
    • Track: N.A.
    • +

      PDT.01 - Product Showcase by Astrazeneca - A Discussion on Treatment Options for Resectable NSCLC and Stage III Unresectable NSCLC

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.02 - Product Showcase by Bayer - Precision Oncology: The Clinical Role of TRK Fusions as the Primary Oncogenic Driver in TRK Fusion Cancer: Program for Lung Specialists

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.03 - Product Showcase by Blueprint Medicines - Changing the Standard of Care for Patients with RET Fusion+ Metastatic NSCLC

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.04 - Product Showcase by Boehringer Ingelheim - Thinking Beyond KRAS G12C Inhibition in NSCLC

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.05 - Product Showcase by Boehringer Ingelheim - Pushing Checkpoint Inhibition Beyond PD-1

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.06 - Product Showcase by Boehringer Ingelheim - What Can We Learn About the Evolving Squamous NSCLC Treatment Landscape? An Expert Discussion on Emerging Real-World Evidence

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.07 - Product Showcase by G1 Therapeutics - Cosela™: A Novel Myeloprotection Therapy

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.08 - Product Showcase by Genentech - Emerging Perspectives in Multidisciplinary Treatment of Early-Stage and Locally Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.09 - Product Showcase by Janssen Biotech - EGFR Exon 20 Insertion Mutations – Emerging Implications for the Management & Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.10 - Product Showcase by Natera - Applications of ctDNA Testing in Lung Cancer: Learning from Other Tumor Types

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.11 - Product Showcase by Oncocyte - DetermaRx – Treatment Stratification in Early-Stage NSCLC

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.12 - Product Showcase by Pfizer - Overview of Efficacy and Safety Data For a First-Line Treatment Option for ALK+ Metastatic NSCLC

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.14 - Product Showcase by Takeda - ALUNBRIG® (brigatinib): A Treatment Option for Patients With Anaplastic Lymphoma Kinase (ALK)–Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.15 - Product Showcase by Thermo Fisher - Next-Generation Sequencing (NGS) in 2021: Impact on Routine Clinical Practice

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

    • +

      PDT.13 - Product Showcase by Pfizer - Multidisciplinary Insights Into Biomarker Testing in Metastatic Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00

      • Abstract

      No abstract available for this presentation

  • +

    MTE01 - Meet the Expert - Targeted Therapies and/or Immunotherapy

    • 05:45 - 06:45
    • 9/08/2021
    • Location: IASLC Booth via Industry Hub and Exhibit Hall
    • Not for CME Credit
    • Type: Meet the Expert Sessions
    • Track: N.A.
    • +

      MTE01.01 - Targeted Therapies and/or Immunotherapy

      05:45 - 06:45  |  Presenter: Luis E. Raez

      • Abstract

      No abstract available for this presentation

  • +

    MTE02 - Meet the Expert - Screening, Incidental Nodules, and Adjuvant Therapy for Early-Stage Lung Cancer

    • 05:45 - 06:45
    • 9/08/2021
    • Location: IASLC Booth via Industry Hub and Exhibit Hall
    • Not for CME Credit
    • Type: Meet the Expert Sessions
    • Track: N.A.
    • +

      MTE02.01 - Screening, Incidental Nodules, and Adjuvant Therapy for Early-Stage Lung Cancer

      05:45 - 06:45  |  Presenter: Paula A. Ugalde Figueroa

      • Abstract

      No abstract available for this presentation

  • +

    PL01 - Opening Plenary: Access and Disparities (Japanese, Mandarin, Spanish Translation Available)

    • 07:00 - 08:00
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL01.01 - Introduction and IASLC Award Presentations

      07:00 - 07:30

      • Abstract

      No abstract available for this presentation

    • +

      PL01.02 - Disparities in Lung Cancer Care Across the Population

      07:30 - 07:40  |  Presenter: Raymond Uyiosa Osarogiagbon

      • Abstract

      Loading...

    • +

      PL01.03 - Disparities in Lung Cancer Care: The Global Burden

      07:40 - 07:50  |  Presenter: Alex Adjei

      • Abstract

      No abstract available for this presentation

    • +

      PL01.04 - Live Discussion with Speakers

      07:50 - 08:00

      • Abstract

      No abstract available for this presentation

  • +

    MA01 - Multimodality Management of Advanced Lung Cancer

    • 08:15 - 09:15
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Multimodality of Advanced Lung Cancer
    • +

      MA01.01 - The Role of Surgery for M1a Non-Small-Cell Lung Cancer with Contralateral Lung Involvement

      08:15 - 08:20  |  Presenter: Arvind Kumar

      • Abstract

      Loading...

    • +

      MA01.02 - Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer

      08:20 - 08:25  |  Presenter: Mara Antonoff

      • Abstract

      Loading...

    • +

      MA01.03 - PREC Multicentre Restrospective Study: A Preoperative Risk Classification for Synchronous Oligometastatic Non-Small Cell Lung Cancer

      08:25 - 08:30  |  Presenter: Luca Bertolaccini

      • Abstract

      Loading...

    • +

      MA01.04 - Discussant

      08:30 - 08:45  |  Presenter: Linda W Martin

      • Abstract

      No abstract available for this presentation

    • +

      MA01.05 - Sintilimab, SBRT and GM-CSF for Advanced NSCLC: Safety Run-in Results of a Prospective, Multicenter, Phase II Trial

      08:45 - 08:50  |  Presenter: Jianjiao Ni

      • Abstract

      Loading...

    • +

      MA01.06 - Effects of the Immunotherapy Era on Maintenance Outcomes in Advanced Nonsquamous NSCLC: Subgroup Analysis of ECOG 5508

      08:50 - 08:55  |  Presenter: Bharathi Muthusamy

      • Abstract

      Loading...

    • +

      MA01.07 - Prognostic Value of STK11 & KRAS Mutations and irAE Incidence in Response to Immunotherapy in Hispanics: A Multicenter Analysis

      08:55 - 09:00  |  Presenter: Fahmin Basher

      • Abstract

      Loading...

    • +

      MA01.08 - Discussant

      09:00 - 09:15  |  Presenter: Karen Reckamp

      • Abstract

      No abstract available for this presentation

  • +

    OA01 - The Impact of COVID-19 on Patients with Lung Cancer

    • 08:15 - 09:15
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      OA01.01 - Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls

      08:15 - 08:25  |  Presenter: Jorge E Gomez

      • Abstract

      Loading...

    • +

      OA01.02 - Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study

      08:25 - 08:35  |  Presenter: Luca Cantini

      • Abstract

      Loading...

    • +

      OA01.03 - Immune Checkpoint Inhibitor Dose Adaptation During the COVID-19 Pandemic in Non-Small Cell Lung Cancer– a Single-Center Experience

      08:35 - 08:45  |  Presenter: Lucie Brigitte Marie Hijmering-Kappelle

      • Abstract

      Loading...

    • +

      OA01.04 - Discussant

      08:45 - 08:55  |  Presenter: Suresh Ramalingam

      • Abstract

      No abstract available for this presentation

    • +

      OA01.05 - Live Discussion with Speakers

      08:55 - 09:05

      • Abstract

      No abstract available for this presentation

  • +

    OA02 - Contemporary Approaches to Supportive Care

    • 08:15 - 09:15
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Palliative and Supportive Care
    • +

      OA02.01 - Assessment of Patient-Reported Outcomes in Lung cancer Patients Treated with Thoracic Radiation

      08:15 - 08:25  |  Presenter: Li Yang

      • Abstract

      Loading...

    • +

      OA02.02 - Development of Machine Learning Model to Estimate Overall Survival in Patients with Advanced NSCLC and ECOG-PS > 1

      08:25 - 08:35  |  Presenter: Mateus Trinconi Cunha

      • Abstract

      Loading...

    • +

      OA02.03 - Medical Assistance in Dying (MAiD) in Patients With Lung Cancer 

      08:35 - 08:45  |  Presenter: Sara Moore

      • Abstract

      Loading...

    • +

      OA02.04 - Phase II Trial of Antiemetic Oral Granisetron Plus Dexamethasone for Nausea and Vomiting Caused by Crizotinib in ALK or ROS1 Fusion-Positive NSCLC

      08:45 - 08:55  |  Presenter: Kenji Kawasumi

      • Abstract

      Loading...

    • +

      OA02.05 - Discussant

      08:55 - 09:05  |  Presenter: Monica Malec

      • Abstract

      No abstract available for this presentation

    • +

      OA02.06 - Live Discussion with Speakers

      09:05 - 09:15

      • Abstract

      No abstract available for this presentation

  • +

    MA02 - RET and Novel Combinations of Osimertinib

    • 09:30 - 10:30
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      MA02.01 - Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial

      09:30 - 09:35  |  Presenter: Shun Lu

      • Abstract

      Loading...

    • +

      MA02.02 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer

      09:35 - 09:40  |  Presenter: Qing Zhou

      • Abstract

      Loading...

    • +

      MA02.03 - MET-Driven Acquired Resistance (AR) in Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

      09:40 - 09:45  |  Presenter: Sai-Hong I. Ou

      • Abstract

      Loading...

    • +

      MA02.04 - Discussant

      09:45 - 10:00  |  Presenter: Shengxiang (Harry) Ren

      • Abstract

      No abstract available for this presentation

    • +

      MA02.05 - A Phase I Study of Afatinib in Combination With Osimertinib in Patients After Failure of Prior Osimertinib

      10:00 - 10:05  |  Presenter: Satoru Miura

      • Abstract

      Loading...

    • +

      MA02.06 - Phase 1b Study of Pelcitoclax (APG-1252) in Combination With Osimertinib in Patients With EGFR TKI-Resistant NSCLC

      10:05 - 10:10  |  Presenter: Li Zhang

      • Abstract

      Loading...

    • +

      MA02.07 - T-DM1 and Osimertinib (TRAEMOS) To Target HER2 Bypass Track Resistance in EGFRm+ NSCLC: Interim Analysis of a Phase II Trial

      10:10 - 10:15  |  Presenter: Merel Jebbink

      • Abstract

      Loading...

    • +

      MA02.08 - Discussant

      10:15 - 10:30  |  Presenter: Adrian G. Sacher

      • Abstract

      No abstract available for this presentation

  • +

    OA03 - Novel Approaches to Cessation in Cancer Care

    • 09:30 - 10:30
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Risk Reduction and Tobacco Control
    • +

      OA03.01 - Implementation of an Opt-Out Smoking Cessation Service for Oncology Patients

      09:30 - 09:40  |  Presenter: Michael Cummings

      • Abstract

      Loading...

    • +

      OA03.02 - Tobacco Cessation Among Patients Undergoing Lung Cancer Screening: Success with Repetition

      09:40 - 09:50  |  Presenter: April Plank

      • Abstract

      Loading...

    • +

      OA03.03 - Patient Factors Associated With Engagement of an Academic Institution Tobacco Cessation Referral Program

      09:50 - 10:00  |  Presenter: Sarah Westergaard

      • Abstract

      Loading...

    • +

      OA03.04 - Discussant

      10:00 - 10:10  |  Presenter: Lawson Eng

      • Abstract

      No abstract available for this presentation

    • +

      OA03.05 - Live Discussion with Speakers

      10:10 - 10:30

      • Abstract

      No abstract available for this presentation

  • +

    OA04 - Improving Thoracic Oncology Patient Outcomes

    • 09:30 - 10:30
    • 9/08/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Nursing and Allied Health Professionals
    • +

      OA04.01 - Preconditioning with Move For Surgery Shortens Hospital Stay after Lung Cancer Surgery

      09:30 - 09:40  |  Presenter: Yogita S. Patel

      • Abstract

      Loading...

    • +

      OA04.02 - Diaphragm and Phrenic Nerve Preservation During Lung-Sparing Surgery for Malignant Pleural Mesothelioma: The Impact on Patient Outcomes

      09:40 - 09:50  |  Presenter: Melissa Jane Culligan

      • Abstract

      Loading...

    • +

      OA04.03 - Feasibility of Prospective Dietetic Assessment and Intervention of Patients Receiving Chemo-Radiotherapy for Lung Cancer

      09:50 - 10:00  |  Presenter: Catherine Samuelson

      • Abstract

      Loading...

    • +

      OA04.04 - Discussant

      10:00 - 10:10  |  Presenter: Carolyn Peddle-McIntyre

      • Abstract

      No abstract available for this presentation

    • +

      OA04.05 - Live Discussion with Speakers

      10:10 - 10:30

      • Abstract

      No abstract available for this presentation